SCHEMBL9045520

SCHEMBL9045520

CC(C)c1ccc(-c2c(Cl)ncnc2NS(=O)(=O)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 4/20 0.51
EDNRB P24530 3/20 0.51
KIT P10721 1/20 0.47
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ESR1 P03372 1/20 0.41
CCR2 P41597 1/20 0.41
LMNA P02545 1/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGS2 P35354 1/20 0.40
POLB P06746 1/20 0.39
PGR P06401 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9046378 0.96 EDNRA (0.57) EDNRAEDNRBKITALDH1A1MAPT
SCHEMBL9046700 0.95 EDNRA (0.49) EDNRAEDNRBKITALDH1A1MAPT
SCHEMBL9043808 0.94 EDNRB (0.47) EDNRAEDNRBKITALDH1A1MAPT
SCHEMBL9053125 0.92 EDNRA (0.47) EDNRAEDNRBKITMAPTKMT2A
SCHEMBL9047430 0.92 EDNRA (0.47) EDNRAEDNRBKITALDH1A1ESR1
SCHEMBL9047883 0.92 EDNRA (0.45) EDNRAEDNRBKITALDH1A1MAPT
SCHEMBL9046552 0.91 EDNRA (0.57) EDNRAEDNRBKITMEN1KMT2A
SCHEMBL9045307 0.88 LMNA (0.43) EDNRAEDNRBKITALDH1A1MAPT
SCHEMBL9045052 0.86 MEN1 (0.55) EDNRAEDNRBALDH1A1MAPTMEN1
SCHEMBL9492453 0.83 EDNRA (0.47) EDNRAEDNRBKITALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed